Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy
CONCLUSION: These findings suggested that a SBRT boost is more effective than the conventional EBRT boost and can be an important treatment option for ICBT-ineligible patients with cervical cancer.STUDY REGISTRATION: This study was registered at the University Hospital Medical Information Network Clinical Trials Registry (UMIN000036845).PMID:38625476 | DOI:10.1007/s11604-024-01566-8
Source: Cancer Control - Category: Cancer & Oncology Authors: Kei Ito Yujiro Nakajima Hiroaki Ogawa Akiko Furusawa Keiko Nemoto Murofushi Satoshi Kito Nao Kino Toshiharu Yasugi Takashi Uno Katsuyuki Karasawa Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | Clinical Trials | Study | Toxicology